Top Markets
Coin of the day
Myrexis, Inc. Myrexis, Inc.

Myrexis, Inc.

MYRX
Rank in Stocks #41164
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially... Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.
Share Price
$0.0011
Last synced: 2026-08-12
Market Cap
$37.93K
Change (1 day)
10.00%
Change (1 year)
450.00%
Country
US
Trade Myrexis, Inc. (MYRX)
Operating Margin for Myrexis, Inc. (MYRX)
Operating Margin as of 2026 TTM: 0.00%
According to Myrexis, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Myrexis, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
US
0.00% -
US
0.00% -
CN
0.00% -
US
0.00% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.